Jan. 30, 2021 – “Our findings suggest that higher storefront cannabis dispensary counts are associated with reduced opioid-related mortality rates at the county level,” the authors write. “While the associations documented cannot be assumed to be causal, they suggest a potential association between increased prevalence of medical and recreational cannabis dispensaries and reduced opioid-related mortality rates.” The study by Greta Hsu, at the University of California, Davis, and Balázs Kovács, at Yale University, was published this week in The BMJ, a respected medical journal previous known as the British Medical Journal. It follows a Canadian study published this week that found legalizing cannabis led to a “marked decline” in the volume of opioids prescribed across Canada.
EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…